Representing the developed world, the United States will maintain a 9.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$206.5 Million to the region's size and clout in the next 5 to 6 years. Over US$165.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Cell Culture will reach a market size of US$198.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 14.7% over the next couple of years and add approximately US$1.3 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others,
- ACEA Biosciences Inc.
- ADMEcell Inc.
- Agilent Technologies Inc.
- Albany Molecular Research Inc.
- Beckman Coulter Inc.
- Cerep SA
- CompuDrug International Inc.
- Cyprotex PLC.
- CeeTox Inc.
- Dassault Systèmes Biovia Corp.
- Eurofins ADME BIOANALYSES SAS
- Galapagos NV
- Molecular Discovery Ltd.
- MultiCASE Inc.
- Optivia Biotechnology
- PerkinElmer Inc.
- Promega Corporation
- Qualyst Inc.
- Simulations Plus Inc.
- Takara Bio Europe AB
- Tecan Group Ltd.
- Thermo Fisher Scientific Inc.
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
ADME-Tox Testing Gains Traction
Recent Market Activity
A Peek into the Impact of ADME-Tox Screening on New Drug Discovery
Current and Future Analysis
US and Europe Dominate, Asia-Pacific Lends Growth Momentum
Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge
Pharma Industry Renews Focus on Cost Optimization
China and India: Hot Spots for R&D Investment
ADME-Tox Assays - An Overview
Introduction of Early In Vitro ADMET Studies
Growing Prominence of Cell-based Assays in Drug Discovery and ADME Analysis
Major Types of Cell-Based HTS Assays for Drug Screening
CROs Expand Presence
Drug Discovery Outsourcing and Type of Services Outsourced
Changing Face of Drug Discovery Outsourcing Activity
M&A - Order of the Day
Global Competitor Market Shares
ADME-Toxicology Testing Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
2. FOCUS ON SELECT PLAYERS
ACEA Biosciences, Inc.
Agilent Technologies, Inc.
Albany Molecular Research, Inc.
Beckman Coulter, Inc.
CompuDrug International, Inc.
Dassault Systèmes Biovia Corp.
Eurofins ADME BIOANALYSES SAS
Molecular Discovery Ltd.
Simulations Plus, Inc.
Taconic Biosciences, Inc.
Takara Bio Europe AB
Tecan Group Ltd.
Thermo Fisher Scientific, Inc.
3. MARKET TRENDS & DRIVERS
Current State of ADME-Tox Testing
Need for Better Models: A Major Factor Driving Innovation in the Market
Focus Shifts to Innovative Approaches
In Silico and In Vitro- the Way to Go
In Vitro Testing Systems and Its Relevance in Drug Development
Growing Inclination towards In-vitro Assays for Toxicology Studies
In Silico ADME-Tox Growing at a Fast Clip
Advantages of Using In Silico Approaches
Factors Hindering Growth
3-D Tissue Bioassays to Enhance In Vitro Toxicity Testing
Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing
Rising Number of Drug Targets Surge Demand for Cell-Based Assays
Growing Focus on the Development of Reproducible and Robust Cell-based Assays
Functional Assays: An Effective Way of Predicting Specific Toxic Effects
GPCR Targets to Drive Growth in Functional Cell Assay Market
New Alternatives for Early-Stage Toxicology Testing
Stem Cells Exude Great Potential in Drug Toxicity Testing
Primary Hepatocytes Become Standard Tool for Evaluation in Hepatic Metabolism
Improved Cryopreservation Technologies Help Expand Use of Hepatocytes
Cardiotoxicity Testing Gains Prominence
Cell Imaging-Gaining Popularity
In Vivo Imaging Persists in ADME-Tox Testing
Computational Models on Rise
Adoption of Data Management Systems
Drug Transporter Analysis Becoming Part of ADME Assessment
Slow Metabolism of Novel Drugs Call for More Human Models in Screening
Further Advances Required for More Understanding of Biotransformation
Introduction of Third Dimension in Cell Culturing Drives Need for New Instrumentation
Regulatory Bodies Focus on Transporter Mediated DDIs
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
Market Facts & Figures
US ADME-Toxicology Testing Market Share (in %) by Company: 2020 & 2025
Market Facts & Figures
European ADME-Toxicology Testing Market: Competitor Market Share Scenario (in %) for 2020 & 2025
REST OF EUROPE
REST OF ASIA-PACIFIC
REST OF LATIN AMERICA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
Total Companies Profiled: 69